|
|
|
| Strategies to Modernize Asset Performance in Pharmaceutical Manufacturing | Join our industry experts for a session that explores how next-generation digital validation technologies (DVTs) turn validation from a document exercise into real-time, data-driven lifecycle intelligence. You’ll learn proven strategies to move from reactive maintenance to predictive, AI-driven optimization, reducing risk, improving uptime, and building scalable, data-driven operational excellence. |
|
|
|
|
|
|
|
|
By Sanjeev Kumar, Denmark | Quality requirements for parenteral drugs complicate facility design like few other regulated products. If you're developing injectables, be aware of these key issues. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Nitrosamines: Assessing The Risk To Pharma Products | Article | By Daniel Regan and Eric Peterson, Lonza | Nitrosamines are a serious risk in drug products, driven by the presence of secondary amines, conducive conditions, and nitrosating agents. Understanding these factors is key to risk mitigation. |
|
|
|
|
| The Way Forward: Supply Chain Solutions | Webinar | Thermo Fisher Scientific | Learn how to build a resilient supply chain to navigate today's complex environment. Expert speakers share insights on optimization, innovation, and strategic planning to meet evolving market conditions. |
|
|
| AI At The Crossroads Of Regulation And Innovation | Audio | Tulip | Examine what it takes to deploy AI responsibly in manufacturing, from evolving validation practices to navigating emerging regulatory expectations and building trustworthy systems that deliver value. |
|
|
| Advancing Drug Development Using In Silico Modeling | White Paper | Thermo Fisher Scientific | When applied strategically, computational modeling can help streamline development timelines, improve process understanding, and reduce the risk associated with critical decisions. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Connect With Pharmaceutical Online: |
|
|
|